{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:11:48Z","timestamp":1780920708893,"version":"3.54.1"},"reference-count":234,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":55,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101155","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T08:16:01Z","timestamp":1772093761000},"page":"101155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospects"],"prefix":"10.1016","volume":"47","author":[{"given":"Usamah","family":"Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed K.","family":"Abdulsahib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.Renuka","family":"Jyothi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya Priyadarshini","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish Singh","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siya","family":"Singla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djamila","family":"Polatova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadhil Faez","family":"Sead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Akhavan-Sigari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2026.101155_bib0001","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/imr.13272","article-title":"Type I interferon and cancer","volume":"321","author":"Holicek","year":"2023","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101155_bib0002","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.it.2017.05.005","article-title":"Type I interferon in chronic virus infection and cancer","volume":"38","author":"Snell","year":"2017","journal-title":"Trends Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1567459","article-title":"Interferon and immunity: the role of microRNA in viral evasion strategies","volume":"16","author":"Bayat","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0004","first-page":"79","article-title":"Type I interferon-mediated tumor immunity and its role in immunotherapy","author":"Yu","year":"2022","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.ctarc.2026.101155_bib0005","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0721-x","article-title":"Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy","volume":"12","author":"Li","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0006","article-title":"Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity","author":"Duong","year":"2021","journal-title":"Immunity."},{"key":"10.1016\/j.ctarc.2026.101155_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI143296","article-title":"Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response","volume":"131","author":"Von Locquenghien","year":"2021","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ctarc.2026.101155_bib0008","article-title":"Opposing roles of type I interferons in cancer immunity","author":"Boukhaled","year":"2020","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101155_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101299","article-title":"Interferon signaling in cancer. Non-canonical pathways and control of intracellular immune checkpoints","volume":"43","author":"Saleiro","year":"2019","journal-title":"Semin. Immunol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0011","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-021-00566-3","article-title":"Interferon-\u03b3: teammate or opponent in the tumour microenvironment?","volume":"22","author":"Gocher","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0012","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00018-022-04219-z","article-title":"Type I interferon-mediated tumor immunity and its role in immunotherapy","volume":"79","author":"Yu","year":"2022","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101155_bib0013","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2217\/fon-2020-0989","article-title":"DNA damage response alterations in gastric cancer: knocking down a new wall","volume":"17","author":"Ricci","year":"2021","journal-title":"Future Oncol. (Lond. Engl.)"},{"key":"10.1016\/j.ctarc.2026.101155_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1362641","article-title":"Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis","volume":"14","author":"Caputo","year":"2024","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0015","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.euo.2023.07.003","article-title":"Real-world outcome of patients with advanced renal cell carcinoma and intermediate- or poor-risk international metastatic renal cell carcinoma database Consortium criteria treated by immune-oncology combinations: differential effectiveness by risk group?","volume":"7","author":"Santoni","year":"2024","journal-title":"Eur. Urol. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101155_bib0016","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/cac2.12072","article-title":"Is post-transplant chemotherapy feasible in liver transplantation for colorectal cancer liver metastases?","volume":"40","author":"Brandi","year":"2020","journal-title":"Cancer Commun. (Lond. Engl.)"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101155_bib0017","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/17474124.2021.1864325","article-title":"BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expert rev. gastroenterol. hepatol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0018","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ejso.2022.12.006","article-title":"Immunonutrition and prehabilitation in pancreatic cancer surgery: a new concept in the era of ERAS\u00ae and neoadjuvant treatment","volume":"49","author":"De Luca","year":"2023","journal-title":"Eur. J. Surg. Oncol. : J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0019","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-020-01154-0","article-title":"Noncoding RNAs in cancer immunity: functions, regulatory mechanisms, and clinical application","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101155_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1191913","article-title":"Exploring the regulatory role of lncRNA in cancer immunity","volume":"13","author":"Zhan","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0021","first-page":"15","article-title":"A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA","author":"Sun","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216219","article-title":"CircRNAs in tumor immunity and immunotherapy: perspectives from innate and adaptive immunity","author":"Yu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ctarc.2026.101155_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2020.05.015","article-title":"Tumor interferon signaling is regulated by a lncRNA INCR1 transcribed from the PD-L1 locus","author":"Mineo","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ctarc.2026.101155_bib0024","first-page":"23","article-title":"Unraveling the advances of non-coding RNAs on the tumor microenvironment: innovative strategies for cancer therapies","author":"Mu","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101155_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2022.10.020","article-title":"The transcription factor IRF2 drives interferon-mediated CD8+ T cell exhaustion to restrict anti-tumor immunity","author":"Lukhele","year":"2022","journal-title":"Immunity."},{"key":"10.1016\/j.ctarc.2026.101155_bib0026","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fmicb.2020.01853","article-title":"Circular RNAs: new epigenetic signatures in viral infections","volume":"11","author":"Nahand","year":"2020","journal-title":"Front. microbiol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0027","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.omtn.2021.03.011","article-title":"Cell death pathways and viruses: role of microRNAs","volume":"24","author":"Nahand","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ctarc.2026.101155_bib0028","doi-asserted-by":"crossref","unstructured":"Sadri Nahand J, Salmaninejad A., Mollazadeh S., Tamehri Zadeh S.S., Rezaee M., Sheida A.H., et al. Virus, exosome, and MicroRNA: new insights into autophagy. Cell biology and translational medicine, volume 17: Stem Cells in Tissue differentiation, Regulation and Disease: Springer; 2022. p. 97\u2013162.","DOI":"10.1007\/5584_2022_715"},{"key":"10.1016\/j.ctarc.2026.101155_bib0029","article-title":"Non-coding RNAs: key players in T cell exhaustion","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0030","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2019.07.019","article-title":"Opposing functions of interferon coordinate adaptive and innate immune responses to cancer immune checkpoint blockade","volume":"178","author":"Benci","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ctarc.2026.101155_bib0031","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41591-018-0302-5","article-title":"Tumor-derived IFN triggers chronic pathway agonism and sensitivity to ADAR loss","volume":"25","author":"Liu","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.ctarc.2026.101155_bib0032","first-page":"43","article-title":"Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction","volume":"4","author":"Qiu","year":"2023","journal-title":"Nat. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0033","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12943-024-02081-0","article-title":"Exosomal miRNAs: the tumor's trojan horse in selective metastasis","volume":"23","author":"Bayat","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101155_bib0034","first-page":"13","article-title":"Exosomal microRNA profiling","author":"Rahimian","year":"2022","journal-title":"MicroRNA Profiling: Methods Protoc."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12935-023-03022-5","article-title":"MiRNA-related metastasis in oral cancer: moving and shaking","volume":"23","author":"Eslami","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ctarc.2026.101155_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2017.03.008","article-title":"Regulation of type I interferon signaling in immunity and inflammation: a comprehensive review","volume":"83","author":"Chen","year":"2017","journal-title":"J. autoimmun."},{"key":"10.1016\/j.ctarc.2026.101155_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.877243","article-title":"Interaction between non-coding RNAs and interferons: with an especial focus on type I interferons","volume":"13","author":"Ghafouri-Fard","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0038","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00334","article-title":"MicroRNA as type I interferon-regulated transcripts and modulators of the Innate Immune response","volume":"6","author":"Forster","year":"2015","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0039","first-page":"24","article-title":"Interferons and resistance mechanisms in tumors and pathogen-driven diseases\u2014Focus on the major histocompatibility complex (MHC) antigen processing pathway","author":"Massa","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101155_bib0040","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.immuni.2019.03.025","article-title":"Shared and distinct functions of type I and type III interferons","volume":"50","author":"Lazear","year":"2019","journal-title":"Immunity."},{"key":"10.1016\/j.ctarc.2026.101155_bib0041","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0042","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fimmu.2017.00029","article-title":"Canonical and non-canonical aspects of JAK\u2013STAT signaling: lessons from interferons for cytokine responses","volume":"8","author":"Majoros","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1190333","article-title":"Dysregulation in IFN-\u03b3 signaling and response: the barricade to tumor immunotherapy","volume":"14","author":"Han","year":"2023","journal-title":"Front. immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0044","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051037","article-title":"Type I and II interferons in the anti-tumor immune response","volume":"13","author":"Fenton","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101155_bib0045","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3389\/fimmu.2017.01661","article-title":"Interferon (IFN)-\u03bb takes the helm: immunomodulatory roles of type III IFNs","volume":"8","author":"Zanoni","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-gamma at the crossroads of Tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"issue":"3-4","key":"10.1016\/j.ctarc.2026.101155_bib0047","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/08830180902978120","article-title":"Molecular mechanisms of IFN-\u03b3 to up-regulate MHC class I antigen processing and presentation","volume":"28","author":"Zhou","year":"2009","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0048","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ctarc.2026.101155_bib0049","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05191-6","article-title":"cGAS-STING pathway mediates activation of dendritic cell sensing of immunogenic tumors","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"key":"10.1016\/j.ctarc.2026.101155_bib0050","doi-asserted-by":"crossref","first-page":"3818","DOI":"10.1158\/1078-0432.CCR-20-2564","article-title":"Type I IFN activating Type I dendritic cells for antitumor immunity","volume":"27","author":"Liang","year":"2021","journal-title":"Clin. Cancer Res."},{"issue":"61","key":"10.1016\/j.ctarc.2026.101155_bib0051","doi-asserted-by":"crossref","first-page":"eabg3570","DOI":"10.1126\/sciimmunol.abg3570","article-title":"NF-\u03bab\u2013dependent IRF1 activation programs cDC1 dendritic cells to drive antitumor immunity","volume":"6","author":"Ghislat","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0052","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1551322","article-title":"IFN-\u03b3-mediated suppression of ANGPT2-Tie2 in endothelial cells facilitates tumor vascular normalization during immunotherapy","volume":"16","author":"Cai","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0053","doi-asserted-by":"crossref","DOI":"10.3390\/biom11050622","article-title":"Functional interfaces, biological pathways, and regulations of interferon-related DNA damage resistance signature (IRDS) genes","volume":"11","author":"Padariya","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.ctarc.2026.101155_bib0054","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00322","article-title":"Plasticity of type I interferon-mediated responses in cancer therapy: from anti-tumor immunity to resistance","volume":"8","author":"Budhwani","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0055","doi-asserted-by":"crossref","DOI":"10.3390\/biology10090856","article-title":"The yin and yang of type I IFNs in cancer promotion and immune activation","volume":"10","author":"Musella","year":"2021","journal-title":"Biology"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0056","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s40364-020-00228-x","article-title":"Roles of IFN-\u03b3 in tumor progression and regression: a review","volume":"8","author":"Jorgovanovic","year":"2020","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ctarc.2026.101155_bib0057","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1089\/jir.2018.0087","article-title":"The interferon-gamma paradox in cancer","volume":"39","author":"Mr","year":"2019","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.ctarc.2026.101155_bib0058","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.cell.2016.11.022","article-title":"Tumor interferon signaling regulates a multigenic resistance program to immune checkpoint blockade","volume":"167","author":"Benci","year":"2016","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101155_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111647","article-title":"Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8+ T cell exhaustion and curtails anti-PD-1 efficacy","volume":"41","author":"Chen","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.ctarc.2026.101155_bib0060","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-020-0530-4","article-title":"Tumor microenvironment complexity and therapeutic implications at a glance","volume":"18","author":"Baghban","year":"2020","journal-title":"Cell Commun. Signal. : CCS"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0061","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"De Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101155_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1547466","article-title":"The role of type I interferon signaling in myeloid anti-tumor immunity","volume":"16","author":"Meyer","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0063","article-title":"Context-dependent activation of STING-interferon signaling by CD11b agonists enhances anti-tumor immunity","author":"Liu","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ctarc.2026.101155_bib0064","first-page":"27","article-title":"Type I interferon signaling regulates myeloid and T cell crosstalk in the glioblastoma tumor microenvironment","author":"Lim","year":"2024","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0065","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a028480","article-title":"Interferon \u03b3 and its important roles in promoting and inhibiting spontaneous and therapeutic cancer immunity","volume":"11","author":"Alspach","year":"2019","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0066","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2021.1929005","article-title":"Double-edged effects of interferons on the regulation of cancer-immunity cycle","volume":"10","author":"Zhang","year":"2021","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.ctarc.2026.101155_bib0067","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1016\/j.csbj.2020.11.048","article-title":"Genetic perturbation of IFN-\u03b1 transcriptional modulators in human endothelial cells uncovers pivotal regulators of angiogenesis","volume":"18","author":"Ciccarese","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ctarc.2026.101155_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1683844","article-title":"From chronic inflammation to immune escape: mapping the tumor microenvironment evolution in renal cell carcinoma","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0069","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nbt.4180","article-title":"Reversal of IDO-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme","volume":"36","author":"Triplett","year":"2018","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12950-024-00417-7","article-title":"Regulatory role of microRNAs in virus-mediated inflammation","volume":"21","author":"Bannazadeh Baghi","year":"2024","journal-title":"J. Inflamm."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0071","article-title":"MicroRNAs and human viral diseases: a focus on the role of microRNA-29","volume":"1871","author":"Kesheh","year":"2025","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"10.1016\/j.ctarc.2026.101155_bib0072","series-title":"Exosomes and MicroRNAs in Biomedical Science","first-page":"1","article-title":"MicroRNA biogenesis and function","author":"Mirzaei","year":"2022"},{"key":"10.1016\/j.ctarc.2026.101155_bib0073","series-title":"MicroRNAs in Cancer. Exosomes and MicroRNAs in Biomedical Science","first-page":"11","author":"Mirzaei","year":"2022"},{"issue":"15","key":"10.1016\/j.ctarc.2026.101155_bib0074","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJMoa0901282","article-title":"MicroRNA expression, survival, and response to interferon in liver cancer","volume":"361","author":"Ji","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101155_bib0075","first-page":"1470","article-title":"Inhibition of cell viability by human IFN-\u03b2 is mediated by microRNA-431","volume":"40","author":"Tanaka","year":"2012","journal-title":"Int. J. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0076","doi-asserted-by":"crossref","first-page":"197","DOI":"10.21873\/cgp.20252","article-title":"MiR-139 induces an interferon-\u03b2 response in prostate cancer cells by binding to RIG-1","volume":"18","author":"Nam","year":"2021","journal-title":"Cancer Genom. Proteom."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101155_bib0077","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1016\/j.febslet.2014.10.004","article-title":"miR-545 inhibited pancreatic ductal adenocarcinoma growth by targeting RIG-I","volume":"588","author":"Song","year":"2014","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0078","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4049\/jimmunol.182.1.39","article-title":"Cutting edge: down-regulation of MHC class I-related chain A on tumor cells by IFN-\u03b3-induced microRNA","volume":"182","author":"Yadav","year":"2009","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0079","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.11","article-title":"socs7, a target gene of microRNA-145, regulates interferon-\u03b2 induction through STAT3 nuclear translocation in bladder cancer cells","volume":"4","author":"Noguchi","year":"2013","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0080","first-page":"3760","article-title":"IFN-\u03b3 induces the upregulation of RFXAP via inhibition of miR-212-3p in pancreatic cancer cells: a novel mechanism for IFN-\u03b3 response","volume":"15","author":"Ding","year":"2018","journal-title":"Oncol. Lett."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101155_bib0081","article-title":"Interferon-\u03b2 induced microRNA-129-5p down-regulates HPV-18 E6 and E7 viral gene expression by targeting SP1 in cervical cancer cells","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS. One"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0082","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117035","article-title":"BANF1 is downregulated by IRF1-regulated microRNA-203 in cervical cancer","volume":"10","author":"Mao","year":"2015","journal-title":"PLoS. One"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0083","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3892\/ijo.2017.3852","article-title":"miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR\/STAT3\/AKT pathway in hepatocellular carcinoma","volume":"50","author":"Yu","year":"2017","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0084","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3892\/ijmm.2016.2612","article-title":"Upregulation of microRNA-450 inhibits the progression of lung cancer in vitro and in vivo by targeting interferon regulatory factor 2","volume":"38","author":"Liu","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0085","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.4049\/jimmunol.1101235","article-title":"MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12\/IFN-\u03b3 pathway, Th1 polarization, and the severity of delayed-type hypersensitivity","volume":"187","author":"Lu","year":"2011","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0086","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/1479-5876-10-241","article-title":"The association of blood angioregulatory microRNA levels with circulating endothelial cells and angiogenic proteins in patients receiving dacarbazine and interferon","volume":"10","author":"Triozzi","year":"2012","journal-title":"J. transl. med."},{"key":"10.1016\/j.ctarc.2026.101155_bib0087","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.7_suppl.462","article-title":"Let-7f microRNA expression within established bladder cancer subtypes and upregulation with recombinant interferon-alpha","author":"Narayan","year":"2019","journal-title":"Am. Soc. Clin. Oncol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0088","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317710410","article-title":"MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells","volume":"39","author":"Zuo","year":"2017","journal-title":"Tumor Biol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0089","first-page":"3261","article-title":"miR\u201129a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3","volume":"40","author":"Liang","year":"2018","journal-title":"Oncol. rep."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0090","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.ymthe.2023.04.019","article-title":"miR-22 gene therapy treats HCC by promoting anti-tumor immunity and enhancing metabolism","volume":"31","author":"Hu","year":"2023","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0091","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/or.2016.4864","article-title":"MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells","volume":"36","author":"Yan","year":"2016","journal-title":"Oncol. Rep."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0092","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbrc.2020.01.034","article-title":"MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down- regulates the expression of interferon regulatory factor-1","volume":"524","author":"Dong","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ctarc.2026.101155_bib0093","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.2147\/OTT.S238975","article-title":"miR-106b-5p inhibits IRF1\/IFN-\u03b2 signaling to promote M2 macrophage polarization of glioblastoma","volume":"13","author":"Shi","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101155_bib0094","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3892\/ol.2020.12123","article-title":"miR-4295 promotes cell proliferation, migration and invasion of osteosarcoma through targeting interferon regulatory factor 1","volume":"20","author":"Cheng","year":"2020","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0095","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/cpr.12223","article-title":"microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression","volume":"48","author":"Li","year":"2015","journal-title":"Cell Prolif."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101155_bib0096","doi-asserted-by":"crossref","first-page":"e2764","DOI":"10.1038\/cddis.2017.145","article-title":"MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer","volume":"8","author":"Liang","year":"2017","journal-title":"Cell Death. Dis."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0097","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jdermsci.2019.05.004","article-title":"MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2","volume":"94","author":"Li","year":"2019","journal-title":"J. Dermatol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0098","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/jgh.13041","article-title":"MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients","volume":"31","author":"Chen","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0099","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41419-019-1685-z","article-title":"MIR17HG-miR-18a\/19a axis, regulated by interferon regulatory factor-1, promotes gastric cancer metastasis via wnt\/\u03b2-catenin signalling","volume":"10","author":"Yuan","year":"2019","journal-title":"Cell Death Dis."},{"issue":"17","key":"10.1016\/j.ctarc.2026.101155_bib0100","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.3390\/ijms21176195","article-title":"ADAR1 suppresses interferon signaling in gastric cancer cells by microRNA-302a-mediated IRF9\/STAT1 regulation","volume":"21","author":"Jiang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0101","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1158\/0008-5472.CAN-18-2207","article-title":"IFN\u03b3-induced IFIT5 promotes epithelial-to-mesenchymal transition in prostate cancer via miRNA processing","volume":"79","author":"Lo","year":"2019","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0102","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152784","article-title":"Screening and identification of epithelial-to-mesenchymal transition-related circRNA and miRNA in prostate cancer","volume":"216","author":"Yan","year":"2020","journal-title":"Pathol.-Res. Pract."},{"key":"10.1016\/j.ctarc.2026.101155_bib0103","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ncrna.2024.08.003","article-title":"ADAR1-regulated miR-142-3p\/RIG-I axis suppresses antitumor immunity in nasopharyngeal carcinoma","volume":"10","author":"Xu","year":"2025","journal-title":"Non-Coding RNA Res."},{"key":"10.1016\/j.ctarc.2026.101155_bib0104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1228458","article-title":"Gold nanoparticles attenuate the interferon-\u03b3 induced SOCS1 expression and activation of NF-\u03bab p65\/50 activity via modulation of microRNA-155-5p in triple-negative breast cancer cells","volume":"14","author":"Farhana","year":"2023","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0105","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1053\/j.gastro.2017.09.045","article-title":"MicroRNAs 15A and 16-1 activate signaling pathways that mediate chemotaxis of immune regulatory B cells to colorectal tumors","volume":"154","author":"Liu","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ctarc.2026.101155_bib0106","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-22641-y","article-title":"MicroRNA-146a limits tumorigenic inflammation in colorectal cancer","volume":"12","author":"Garo","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0107","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1158\/0008-5472.CAN-18-1397","article-title":"miR-146a controls immune response in the Melanoma microenvironment","volume":"79","author":"Mastroianni","year":"2018","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0108","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.celrep.2012.10.025","article-title":"Epistasis between microRNAs 155 and 146a during T cell-mediated antitumor immunity","volume":"2","author":"Huffaker","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.ctarc.2026.101155_bib0109","doi-asserted-by":"crossref","DOI":"10.1038\/s41389-018-0106-y","article-title":"miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a\/IL-1ra pathway in mouse breast cancer","volume":"7","author":"Wang","year":"2018","journal-title":"Oncogenesis."},{"key":"10.1016\/j.ctarc.2026.101155_bib0110","article-title":"microRNA-144\/451 decreases dendritic cell bioactivity via targeting interferon-regulatory factor 5 to limit DSS-induced colitis","volume":"13","author":"Lin","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0111","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1007\/s13402-023-00839-0","article-title":"Modulation of miR-146b by N6-methyladenosine modification remodels tumor-associated macrophages and enhances anti-PD-1 therapy in colorectal cancer","volume":"46","author":"He","year":"2023","journal-title":"Cell. Oncol. (Dordr.)"},{"issue":"13","key":"10.1016\/j.ctarc.2026.101155_bib0112","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1158\/0008-5472.CAN-12-4318","article-title":"miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma","volume":"73","author":"Wei","year":"2013","journal-title":"Cancer res."},{"key":"10.1016\/j.ctarc.2026.101155_bib0113","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.668534","article-title":"MicroRNAs regulating tumor immune response in the prediction of the outcome in patients with breast cancer","volume":"8","author":"Thomopoulou","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ctarc.2026.101155_bib0114","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9040421","article-title":"MicroRNAs regulating tumor and immune cell interactions in the prediction of relapse in early stage breast cancer","volume":"9","author":"Papadaki","year":"2021","journal-title":"Biomedicines."},{"key":"10.1016\/j.ctarc.2026.101155_bib0115","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1038\/onc.2013.258","article-title":"MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of fra-1 proto-oncogene","volume":"33","author":"Yang","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ctarc.2026.101155_bib0116","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1160719","article-title":"Advances in the role of STAT3 in macrophage polarization","volume":"14","author":"Xia","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0117","doi-asserted-by":"crossref","first-page":"695","DOI":"10.21037\/jgo-22-237","article-title":"miRNA-320 inhibits colitis-associated colorectal cancer by regulating the IL-6R\/STAT3 pathway in mice","volume":"13","author":"Wu","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0118","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.01448","article-title":"Fine-tuning of type I interferon response by STAT3","volume":"10","author":"Tsai","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0119","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1291106","article-title":"JAK-STAT-mediated chronic inflammation impairs cytotoxic T lymphocyte activation to decrease anti-PD-1 immunotherapy efficacy in pancreatic cancer","volume":"6","author":"Lu","year":"2017","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.ctarc.2026.101155_bib0120","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11122002","article-title":"A double-edged sword of immune regulation and cancer progression","volume":"11","author":"Owen","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101155_bib0121","doi-asserted-by":"crossref","DOI":"10.1177\/1758835920937890","article-title":"Long non-coding RNA LINC00473 acts as a microRNA-29a-3p sponge to promote hepatocellular carcinoma development by activating Robo1-dependent PI3K\/AKT\/mTOR signaling pathway","volume":"12","author":"Song","year":"2020","journal-title":"Ther. Adv. Med. Oncol."},{"issue":"4","key":"10.1016\/j.ctarc.2026.101155_bib0122","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.bbrc.2018.04.219","article-title":"Long noncoding RNA PVT1 inhibits interferon-\u03b1 mediated therapy for hepatocellular carcinoma cells by interacting with signal transducer and activator of transcription 1","volume":"500","author":"Ding","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ctarc.2026.101155_bib0123","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1609165","article-title":"Utilization of artificial circular RNAs as miRNA sponges and anti-PD-1 scFv expression platforms to suppress hepatocellular carcinoma progression","volume":"16","author":"Lai","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0124","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.canlet.2015.01.003","article-title":"IFN-\u03b3-mediated IRF1\/miR-29b feedback loop suppresses colorectal cancer cell growth and metastasis by repressing IGF1","volume":"359","author":"Yuan","year":"2015","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbrc.2020.01.034","article-title":"MicroRNA-301a (miR-301a) is induced in hepatocellular carcinoma (HCC) and down-regulates the expression of interferon regulatory factor-1","volume":"524","author":"Dong","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0126","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/cpr.12223","article-title":"micro RNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF 7 expression","volume":"48","author":"Li","year":"2015","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ctarc.2026.101155_bib0127","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biocel.2017.12.017","article-title":"Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2","volume":"95","author":"J-j","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101155_bib0128","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.145","article-title":"MicroRNA-18a-5p functions as an oncogene by directly targeting IRF2 in lung cancer","volume":"8","author":"Liang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ctarc.2026.101155_bib0129","first-page":"24","article-title":"MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1\/PD-L1 and CTLA-4 pathways","author":"Touchaei","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ctarc.2026.101155_bib0130","first-page":"25","article-title":"miRNAs related to Immune checkpoint inhibitor response: a systematic review","author":"Garc\u00eda-Gim\u00e9nez","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101155_bib0131","doi-asserted-by":"crossref","DOI":"10.1111\/febs.14030","article-title":"Noncoding RNAs and immune checkpoints\u2014Clinical implications as cancer therapeutics","volume":"284","author":"Smolle","year":"2017","journal-title":"FEBS J."},{"key":"10.1016\/j.ctarc.2026.101155_bib0132","article-title":"Targeting non-coding RNAs to overcome cancer therapy resistance","volume":"7","author":"Chen","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101155_bib0133","first-page":"2205","article-title":"IRF-1 mediated long non-coding RNA PVT1-214 promotes oxaliplatin resistance of colorectal cancer via miR-128 inhibition","volume":"25","author":"Tong","year":"2020","journal-title":"J. Buon."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0134","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41419-023-05609-2","article-title":"LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1\u2013TINCR-USP20-PD-L1 axis","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ctarc.2026.101155_bib0135","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2024.1471100","article-title":"Long non-coding RNA GRASLND links melanoma differentiation and interferon-gamma response","volume":"11","author":"Fischer","year":"2024","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ctarc.2026.101155_bib0136","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3389\/fimmu.2014.00676","article-title":"Regulation of interferon-stimulated gene BST2 by a lncRNA transcribed from a shared bidirectional promoter","volume":"5","author":"Kambara","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0137","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12672-024-01134-6","article-title":"lncRNA FLJ20021 regulates CDK1-mediated PANoptosis in a ZBP1-dependent manner to increase the sensitivity of laryngeal cancer-resistant cells to cisplatin","volume":"15","author":"Yin","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0138","first-page":"35","article-title":"Lnc-CCNH-8 promotes immune escape by up-regulating PD-L1 in hepatocellular carcinoma","author":"Zhao","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ctarc.2026.101155_bib0139","first-page":"35","article-title":"Deciphering the shield: lnc-CCNH-8\u2019s pivotal role in crafting PD-L1-mediated immune camouflage in hepatocellular carcinoma","author":"Song","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ctarc.2026.101155_bib0140","article-title":"Qntrolling the LncRNA HULC-tregs-PD-1 axis inhibits immune escape in the tumor microenvironment","volume":"10","author":"Wang","year":"2024","journal-title":"Heliyon."},{"key":"10.1016\/j.ctarc.2026.101155_bib0141","first-page":"25","article-title":"Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis","author":"Vanan","year":"2025","journal-title":"Clin. Exp. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101155_bib0142","doi-asserted-by":"crossref","first-page":"10386","DOI":"10.1002\/jcp.27705","article-title":"Long-noncoding RNA HOTAIR inhibits immunologic rejection of mouse leukemia cells through activating the wnt\/\u03b2-catenin signaling pathway in a mouse model of leukemia","volume":"234","author":"Li","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2023.154957","article-title":"HOTAIR: a key regulator of the wnt\/\u03b2-catenin signaling cascade in cancer progression and treatment","volume":"253","author":"Hakami","year":"2024","journal-title":"Pathol.-Res. Pract."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101155_bib0144","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102065","article-title":"A novel LncRNA PTH-AS upregulates interferon-related DNA damage resistance signature genes and promotes metastasis in human breast cancer xenografts","volume":"298","author":"Akimoto","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101155_bib0145","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312920","article-title":"HOXA11-As promotes lymph node metastasis through regulation of IFNL and HMGB Family genes in pancreatic cancer","volume":"25","author":"Nishiyama","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.ctarc.2026.101155_bib0146","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312920","article-title":"HOXA11-As promotes lymph node metastasis through regulation of IFNL and HMGB Family genes in pancreatic cancer","volume":"25","author":"Nishiyama","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101155_bib0147","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.omtn.2019.10.039","article-title":"Long noncoding RNA LINC01116 contributes to gefitinib resistance in non-small cell lung cancer through regulating IFI44","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Ther. Nucleic. Acids."},{"key":"10.1016\/j.ctarc.2026.101155_bib0148","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.omtn.2019.10.039","article-title":"Long noncoding RNA LINC01116 contributes to gefitinib resistance in non-small cell lung cancer through regulating IFI44","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ctarc.2026.101155_bib0149","article-title":"Long non-coding RNA LINC00847 induced by E2F1 accelerates non-small cell lung cancer progression through targeting miR-147a\/IFITM1 axis","volume":"8","author":"Li","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.ctarc.2026.101155_bib0150","article-title":"Long non-coding RNA LINC00847 induced by E2F1 accelerates non-small cell lung cancer progression through targeting miR-147a\/IFITM1 axis","volume":"8","author":"Li","year":"2021","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0151","article-title":"ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a\/IRF-2 signaling pathway","volume":"24","author":"Xiao","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ctarc.2026.101155_bib0152","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110316","article-title":"The AhR regulates IFN-induced immune checkpoints in lung cancer cells through HNRNPH1, an RNA-binding protein, and INCR1, a novel long non-coding RNA","author":"Lara","year":"2025","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0153","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-99736-5","article-title":"DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes","volume":"11","author":"Hatanaka","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ctarc.2026.101155_bib0154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02142-0","article-title":"LncRNA CTD-3252C9. 4 modulates pancreatic cancer cell survival and apoptosis through regulating IFI6 transcription","volume":"21","author":"Yin","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ctarc.2026.101155_bib0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216463","article-title":"LINC00926 promotes progression of renal cell carcinoma via regulating miR-30a-5p\/SOX4 axis and activating ifn\u03b3-JAK2-STAT1 pathway","volume":"578","author":"Du","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0156","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165554","article-title":"Granulocytic myeloid-derived suppressor cells contribute to IFN-I signaling activation of B cells and disease progression through the lncRNA NEAT1-BAFF axis in systemic lupus erythematosus","volume":"1866","author":"Dong","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0157","article-title":"Targeting TSPEAR-AS2 suppresses tumor growth and interferon signaling in esophageal cancer","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101155_bib0158","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/iub.2033","article-title":"Silence of long noncoding RNA NEAT1 exerts suppressive effects on immunity during sepsis by promoting microRNA-125-dependent MCEMP1 downregulation","volume":"71","author":"Chen","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ctarc.2026.101155_bib0159","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s43018-021-00196-7","article-title":"The IRENA lncRNA converts chemotherapy-polarized tumor-suppressing macrophages to tumor-promoting phenotypes in breast cancer","volume":"2","author":"Liu","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ctarc.2026.101155_bib0160","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.79811","article-title":"VPS9D1-AS1 overexpression amplifies intratumoral TGF-\u03b2 signaling and promotes tumor cell escape from CD8(+) T cell killing in colorectal cancer","volume":"11","author":"Yang","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.ctarc.2026.101155_bib0161","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1158\/2326-6066.CIR-21-1011","article-title":"Long noncoding RNA MIR4435-2HG suppresses colorectal cancer initiation and progression by reprogramming neutrophils","volume":"10","author":"Yu","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.ctarc.2026.101155_bib0162","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41588-018-0252-3","article-title":"Long non-coding RNA MALAT1 suppresses breast cancer metastasis","volume":"50","author":"Kim","year":"2018","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101155_bib0163","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1002\/cam4.1524","article-title":"Long non-coding RNA GAS5 is induced by interferons and plays an antitumor role in esophageal squamous cell carcinoma","volume":"7","author":"Huang","year":"2018","journal-title":"Cancer Med."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101155_bib0164","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1002\/cam4.1524","article-title":"Long non-coding RNA GAS 5 is induced by interferons and plays an antitumor role in esophageal squamous cell carcinoma","volume":"7","author":"Huang","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.ctarc.2026.101155_bib0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2019.05.038","article-title":"Interferon-inducible lncRNA IRF1-AS represses esophageal squamous cell carcinoma by promoting interferon response","volume":"459","author":"Huang","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ctarc.2026.101155_bib0166","first-page":"676","article-title":"Regulation of interferon-stimulated gene BST2 by a lncRNA transcribed from a shared bidirectional promoter","volume":"5","author":"Kambara","year":"2014","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101155_bib0167","doi-asserted-by":"crossref","DOI":"10.4149\/neo_2020_191014N1034","article-title":"Long non-coding RNA GAS5 promotes natural killer cell cytotoxicity against gastric cancer by regulating miR-18a","volume":"67","author":"Wei","year":"2020","journal-title":"Neoplasma"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0168","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1753425919827632","article-title":"LncRNA GAS5 enhanced the killing effect of NK cell on liver cancer through regulating miR-544\/RUNX3","volume":"25","author":"Fang","year":"2019","journal-title":"Innate Immun."},{"key":"10.1016\/j.ctarc.2026.101155_bib0169","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2022.153856","article-title":"Long noncoding RNA GAS5 inhibits proliferation and metastasis in papillary thyroid carcinoma through the IFN\/STAT1 signaling pathway","volume":"233","author":"Xu","year":"2022","journal-title":"Pathol.-Res. Pract."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0170","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.canlet.2016.08.024","article-title":"Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis","volume":"382","author":"Wang","year":"2016","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0171","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41420-024-01997-2","article-title":"NAT10-mediated upregulation of GAS5 facilitates immune cell infiltration in non-small cell lung cancer via the MYBBP1A-p53\/IRF1\/type I interferon signaling axis","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0172","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2022.113438","article-title":"Long noncoding RNA RFPL1S-202 inhibits ovarian cancer progression by downregulating the IFN-\u03b2\/STAT1 signaling","volume":"422","author":"Liu","year":"2023","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0173","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-31306-8","article-title":"A Kelch domain-containing KLHDC7B and a long non-coding RNA ST8SIA6-AS1 act oppositely on breast cancer cell proliferation via the interferon signaling pathway","volume":"8","author":"Jeong","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101155_bib0174","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41419-023-05609-2","article-title":"LncRNA TINCR impairs the efficacy of immunotherapy against breast cancer by recruiting DNMT1 and downregulating MiR-199a-5p via the STAT1-TINCR-USP20-PD-L1 axis","volume":"14","author":"Wang","year":"2023","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.ctarc.2026.101155_bib0175","article-title":"HOTAIR: a key regulator of the wnt\/\u03b2-catenin signaling cascade in cancer progression and treatment","volume":"253","author":"Hakami","year":"2024","journal-title":"Pathol. Res. Pr."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0176","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1186\/s12885-021-08331-4","article-title":"Hsa_circ_0000301 facilitates the progression of cervical cancer by targeting miR-1228-3p\/IRF4 axis","volume":"21","author":"Deng","year":"2021","journal-title":"BMC. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0177","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/HJH.0000000000003887","article-title":"CircPCNXL2 promotes preeclampsia progression by suppressing trophoblast cell proliferation and invasion via miR-487a-3p\/interferon regulatory factor 2 axis","volume":"43","author":"Xu","year":"2025","journal-title":"J. Hypertens."},{"issue":"11","key":"10.1016\/j.ctarc.2026.101155_bib0178","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1002\/jcb.29620","article-title":"Circular RNA circ-EGLN3 promotes renal cell carcinoma proliferation and aggressiveness via miR-1299-mediated IRF7 activation","volume":"121","author":"Lin","year":"2020","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ctarc.2026.101155_bib0179","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.omtn.2020.08.001","article-title":"hsa_circ_0003738 inhibits the suppressive function of tregs by targeting miR-562\/IL-17A and miR-490-5p\/IFN-\u03b3 signaling pathway","volume":"21","author":"Yang","year":"2020","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0180","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/26895293.2021.1879279","article-title":"CircRNA_100920 enhanced oncolytic adenovirus therapy in colon cancer by suppressing IFN-\u03b3 expression","volume":"14","author":"Yuan","year":"2021","journal-title":"All. Life"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0181","doi-asserted-by":"crossref","first-page":"7243","DOI":"10.1038\/s41467-022-34872-8","article-title":"circCsnk1g3-and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment","volume":"13","author":"Piras","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101155_bib0182","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108918","article-title":"Circ_0008287 promotes immune escape of gastric cancer cells through impairing microRNA-548c-3p-dependent inhibition of CLIC1","volume":"111","author":"Li","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0183","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.omtn.2020.08.001","article-title":"hsa_circ_0003738 inhibits the suppressive function of tregs by targeting miR-562\/IL-17A and miR-490-5p\/IFN-\u03b3 signaling pathway","volume":"21","author":"Yang","year":"2020","journal-title":"Mol. Ther.-Nucleic Acids"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0184","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/jcmm.16105","article-title":"Circular RNA hsa_circ_0000658 inhibits osteosarcoma cell proliferation and migration via the miR-1227\/IRF2 axis","volume":"25","author":"Jiang","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ctarc.2026.101155_bib0185","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.biocel.2017.12.017","article-title":"Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2","volume":"95","author":"Jin","year":"2018","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0186","doi-asserted-by":"crossref","first-page":"7479","DOI":"10.2147\/OTT.S238975","article-title":"miR-106b-5p inhibits IRF1\/IFN-\u03b2 signaling to promote M2 macrophage polarization of glioblastoma","author":"Shi","year":"2020","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0187","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007578","article-title":"Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1\/miR-218-5p network","volume":"15","author":"Li","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ctarc.2026.101155_bib0188","article-title":"Noncoding RNAs: the shot callers in tumor immune escape","volume":"5","author":"Liu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ctarc.2026.101155_bib0189","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104821","article-title":"Review of long non-coding RNAs in the cancer\u2013Immunity cycle: mechanisms and therapeutic implications","volume":"26","author":"Perez-Medina","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101155_bib0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2025.110316","article-title":"The AhR regulates IFN-induced immune checkpoints in lung cancer cells through HNRNPH1, an RNA-binding protein, and INCR1, a novel long non-coding RNA","volume":"301","author":"Lara","year":"2025","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ctarc.2026.101155_bib0191","first-page":"15","article-title":"Non-coding RNAs as epigenetic regulators of immune checkpoints in cancer immunity","author":"Saadi","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.ctarc.2026.101155_bib0192","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34872-8","article-title":"circCsnk1g3- and circAnkib1-regulated interferon responses in sarcoma promote tumorigenesis by shaping the immune microenvironment","volume":"13","author":"Piras","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101155_bib0193","first-page":"23","article-title":"CircRNAs: functions and emerging roles in cancer and immunotherapy","author":"Wang","year":"2025","journal-title":"BMC Med."},{"key":"10.1016\/j.ctarc.2026.101155_bib0194","article-title":"The role of NcRNAs to regulate immune checkpoints in cancer","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0195","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-05647-w","article-title":"Regulation of the tumor immune microenvironment by cancer-derived circular RNAs","volume":"14","author":"Guan","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ctarc.2026.101155_bib0196","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-020-00848-8","article-title":"The role of cancer-derived microRNAs in cancer immune escape","volume":"13","author":"Yi","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0197","first-page":"286","article-title":"Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment","author":"Omar","year":"2019","journal-title":"FEBS J."},{"key":"10.1016\/j.ctarc.2026.101155_bib0198","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-023-00530-4","article-title":"Novel role of immune-related non-coding RNAs as potential biomarkers regulating tumour immunoresponse via MICA\/NKG2D pathway","volume":"11","author":"Zhang","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ctarc.2026.101155_bib0199","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-025-04105-1","article-title":"Exosomal regulation of cellular reprogramming and polarization in the tumor microenvironment","author":"Bayat","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s12935-025-03786-y","article-title":"To be or not to be: navigating the influence of MicroRNAs on cervical cancer cell death","volume":"25","author":"Taghizadieh","year":"2025","journal-title":"Cancer Cell Int."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101155_bib0201","article-title":"The tumor microenvironment's gambit: exosomal pawns on the board of head and neck cancer","volume":"1879","author":"Mohamadi","year":"2024","journal-title":"Biochim. Biophys. Acta (BBA)-Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101155_bib0202","doi-asserted-by":"crossref","DOI":"10.3892\/mco.2020.2193","article-title":"Multiple microRNAs as biomarkers for early breast cancer diagnosis","volume":"14","author":"Jang","year":"2020","journal-title":"Mol. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101155_bib0203","doi-asserted-by":"crossref","first-page":"162","DOI":"10.32471\/exp-oncology.2312-8852.vol-42-no-3.14805","article-title":"Association of circulating miR-21, -205, and -182 with response of luminal breast cancers to neoadjuvant FAC and AC treatment","volume":"42","author":"Chekhun","year":"2020","journal-title":"Exp. Oncol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0204","first-page":"47","article-title":"Regulatory roles of miR-155-5p, miR-21-5p, miR-93-5p, and miR-140-5p in breast cancer progression","author":"Degheidy","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0205","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36321-3","article-title":"Plasma miR-21, miR-155, miR-10b, and let-7a as the potential biomarkers for the monitoring of breast cancer patients","volume":"8","author":"Khalighfard","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0206","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11010-018-3462-1","article-title":"Role of miRNA-210, miRNA-21 and miRNA-126 as diagnostic biomarkers in colorectal carcinoma: impact of HIF-1\u03b1-VEGF signaling pathway","volume":"454","author":"Sabry","year":"2019","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ctarc.2026.101155_bib0207","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.21873\/invivo.11383","article-title":"Expression of circulating miR-155, miR-21, miR-221, miR-30a, miR-34a and miR-29a: comparison of colonic and rectal cancer","volume":"32","author":"Orosz","year":"2018","journal-title":"In Vivo"},{"key":"10.1016\/j.ctarc.2026.101155_bib0208","doi-asserted-by":"crossref","DOI":"10.3390\/ncrna11020026","article-title":"A miRNA signature for non-invasive colorectal cancer diagnosis in Morocco: miR-21, miR-29a and miR-92a","volume":"11","author":"Fathi","year":"2025","journal-title":"Non-Coding RNA"},{"key":"10.1016\/j.ctarc.2026.101155_bib0209","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0893-y","article-title":"Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer","volume":"17","author":"Zhan","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ctarc.2026.101155_bib0210","doi-asserted-by":"crossref","DOI":"10.1373\/clinchem.2018.301150","article-title":"Noncoding RNAs serve as diagnosis and prognosis biomarkers for hepatocellular carcinoma","author":"Tan","year":"2019","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ctarc.2026.101155_bib0211","first-page":"24","article-title":"Diagnostic significance of hsa-miR-21-5p, hsa-miR-192-5p, hsa-miR-155-5p, hsa-miR-199a-5p panel and ratios in hepatocellular carcinoma on top of liver cirrhosis in HCV-infected patients","author":"Eldosoky","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0212","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s43556-025-00401-4","article-title":"CAR-engineered cell therapies: current understandings and future perspectives","volume":"7","author":"Bayat","year":"2026","journal-title":"Mol. Biomed."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0213","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10142-025-01612-2","article-title":"The CRISPR-Cas revolution in head and neck cancer: a new era of targeted therapy","volume":"25","author":"Hashemi","year":"2025","journal-title":"Funct. Integr. Genom."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0214","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10565-024-09907-z","article-title":"Let's make it personal: CRISPR tools in manipulating cell death pathways for cancer treatment","volume":"40","author":"Bayat","year":"2024","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.ctarc.2026.101155_bib0215","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1590\/0001-3765202520240565","article-title":"Prognostic significance and therapeutic outcome prediction through serum miR-21 and miR-145 in ovarian cancer","volume":"97","author":"Zhong","year":"2025","journal-title":"An. Acad. Bras. Cienc."},{"key":"10.1016\/j.ctarc.2026.101155_bib0216","first-page":"25","article-title":"miR-21 and miR-145 as prognostic biomarkers for radiotherapy responses in cervical cancer patients: a preliminary study","author":"Putra","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ctarc.2026.101155_bib0217","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206542","article-title":"miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer","volume":"13","author":"Campayo","year":"2018","journal-title":"PLoS. One"},{"key":"10.1016\/j.ctarc.2026.101155_bib0218","article-title":"A 5-MicroRNA signature identified from serum MicroRNA profiling predicts survival in patients with advanced stage non-small cell lung cancer","author":"Zhang","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ctarc.2026.101155_bib0219","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2020.05.022","article-title":"Circulating miRNAs and extracellular vesicle containing miRNAs as response biomarkers of anti PD-1\/PD-L1 therapy in non-small-cell lung cancer","author":"Shukuya","year":"2020","journal-title":"J. Thorac. Oncol. : Off. Publ. Int. Assoc. Study Lung Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0220","first-page":"319","article-title":"Exosome\u2011encapsulated microRNA\u201123b as a minimally invasive liquid biomarker for the prediction of recurrence and prognosis of gastric cancer patients in each tumor stage","volume":"40","author":"Kumata","year":"2018","journal-title":"Oncol. rep."},{"key":"10.1016\/j.ctarc.2026.101155_bib0221","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-018-1640-2","article-title":"Systematic analysis of lncRNA\u2013miRNA\u2013mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer","volume":"16","author":"Fan","year":"2018","journal-title":"J. Transl. Med."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101155_bib0222","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/1878-0261.12188","article-title":"Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer","volume":"12","author":"Xie","year":"2018","journal-title":"Mol. Oncol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101155_bib0223","doi-asserted-by":"crossref","first-page":"e1425","DOI":"10.1002\/ctm2.1425","article-title":"Non-coding RNAs in cancer immunotherapy: predictive biomarkers and targets","volume":"13","author":"Alahdal","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.ctarc.2026.101155_bib0224","first-page":"2023","article-title":"Noncoding RNAs as an emerging resistance mechanism to immunotherapies in cancer: basic evidence and therapeutic implications","volume":"Volume 14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101155_bib0225","doi-asserted-by":"crossref","first-page":"11179","DOI":"10.1007\/s00210-025-04055-5","article-title":"Battlegrounds of treatment resistance: decoding the tumor microenvironment","volume":"398","author":"Bayat","year":"2025","journal-title":"Naunyn. Schmiedeb. Arch. Pharmacol."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101155_bib0226","article-title":"Viral nanoparticles-mediated delivery of therapeutic cargo","volume":"6","author":"Zanganeh","year":"2023","journal-title":"Adv. Ther."},{"issue":"22","key":"10.1016\/j.ctarc.2026.101155_bib0227","doi-asserted-by":"crossref","first-page":"6905","DOI":"10.7150\/jca.57477","article-title":"TUG1 promotes the expression of IFITM3 in hepatocellular carcinoma by competitively binding to miR-29a","volume":"12","author":"Liu","year":"2021","journal-title":"J. Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101155_bib0228","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1038\/s41418-022-00970-9","article-title":"Long noncoding RNA NEAT1 promotes ferroptosis by modulating the miR-362-3p\/MIOX axis as a ceRNA","volume":"29","author":"Zhang","year":"2022","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0229","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12943-019-1111-2","article-title":"Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells","volume":"18","author":"Zhang","year":"2019","journal-title":"Mol. Cancer"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101155_bib0230","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102734","article-title":"siRNA nanoparticle targeting PD-L1 activates tumor immunity and abrogates pancreatic cancer growth in humanized preclinical model","volume":"10","author":"Jung","year":"2021","journal-title":"Cells"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101155_bib0231","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1038\/leu.2015.124","article-title":"Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo","volume":"29","author":"Morelli","year":"2015","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.ctarc.2026.101155_bib0232","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1158\/1078-0432.CCR-22-3836","article-title":"A tumor-suppressive molecular axis EP300\/circRERE\/miR-6837-3p\/MAVS activates type I IFN pathway and antitumor immunity to suppress colorectal cancer","volume":"29","author":"Ding","year":"2023","journal-title":"Clin. Cancer Res."},{"issue":"15_suppl","key":"10.1016\/j.ctarc.2026.101155_bib0233","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2009.27.15_suppl.e16522","article-title":"Regulation of the EGFR-E2F3a axis by the interferon regulatory factor (IRFs) and by promoter methylation of miR-34a in ovarian cancer","volume":"27","author":"Reimer","year":"2009","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101155_bib0234","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12951-024-02485-6","article-title":"Engineered nanoparticles promote cardiac tropism of AAV vectors","volume":"22","author":"Switala","year":"2024","journal-title":"J. Nanobiotechnol."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226000663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226000663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:48:33Z","timestamp":1780919313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226000663"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":234,"alternative-id":["S2468294226000663"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101155","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospects","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101155"}}